Cargando…
Fingolimod inhibits proliferation and epithelial–mesenchymal transition in sacral chordoma by inactivating IL-6/STAT3 signalling
Purpose: To explore the sensitivity of the immunosuppressive agent fingolimod (FTY720) in chordoma and determine whether it can serve as an appropriate alternate treatment for unresectable tumours in patients after incomplete surgery. Methods: Cell viability assays, colony formation assays and EdU a...
Autores principales: | Wang, Jiaqi, Hu, Wenhao, Du, Xiaowen, Sun, Ying, Han, Shuai, Tu, Guanjun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7029154/ https://www.ncbi.nlm.nih.gov/pubmed/32027356 http://dx.doi.org/10.1042/BSR20200221 |
Ejemplares similares
-
Retraction: Fingolimod inhibits proliferation and epithelial- mesenchymal transition in sacral chordoma by inactivating IL-6/STAT3 signaling
Publicado: (2020) -
Expression of Concern: Fingolimod inhibits proliferation and epithelial–mesenchymal transition in sacral chordoma by inactivating IL-6/STAT3 signaling
Publicado: (2020) -
Sacral Chordoma: Challenging for Resection Margin
por: Lee, Seung-Hyun, et al.
Publicado: (2014) -
STEAP1 facilitates metastasis and epithelial–mesenchymal transition of lung adenocarcinoma via the JAK2/STAT3 signaling pathway
por: Huo, Shu-fen, et al.
Publicado: (2020) -
Epithelial–mesenchymal transition and its transcription factors
por: Debnath, Pallabi, et al.
Publicado: (2021)